Velge Bertrand 4

4 · LifeMD, Inc. · Filed Dec 7, 2021

Insider Transaction Report

Form 4

Period: 2019-09-30

LifeMD, Inc.LFMD

Velge Bertrand

Director

Transactions

Award
Common Stock
2020-08-05+173,234→ 684,743 total
Purchase
Common Stock
2020-09-22$0.65/sh+96,923$63,000→ 781,666 total
Award
Stock Option (Right to Buy)
2019-09-30+2,500→ 2,500 total
Exercise: $1.15From: 2019-09-30Exp: 2024-09-30→ Common Stock (2,500 underlying)
Purchase
Common Stock
2020-04-15$0.17/sh+294,118$50,000→ 511,509 total
Purchase
Common Stock
2021-12-03$3.91/sh+110,000$430,100→ 891,666 total(indirect: By LLC)
Award
Stock Option (Right to Buy)
2019-12-31+2,500→ 2,500 total
Exercise: $1.15From: 2019-12-31Exp: 2024-12-31→ Common Stock (2,500 underlying)
Award
Warrants to Purchase Common Stock
2020-09-22+100,000→ 100,000 total
Exercise: $4.65From: 2020-09-22Exp: 2024-09-22→ Common Stock (100,000 underlying)
Award
Stock Option (Right to Buy)
2020-09-30+2,500→ 2,500 total
Exercise: $7.95From: 2020-09-30Exp: 2025-09-30→ Common Stock (2,500 underlying)
Award
Stock Option (Right to Buy)
2021-03-31+2,500→ 2,500 total
Exercise: $11.98From: 2021-03-31Exp: 2026-03-31→ Common Stock (2,500 underlying)
Award
Stock Option (Right to Buy)
2020-03-31+2,500→ 2,500 total
Exercise: $1.20From: 2021-03-31Exp: 2025-03-31→ Common Stock (2,500 underlying)
Award
Stock Option (Right to Buy)
2020-12-31+2,500→ 2,500 total
Exercise: $7.00From: 2020-12-31Exp: 2025-12-31→ Common Stock (2,500 underlying)
Award
Stock Option (Right to Buy)
2020-06-30+2,500→ 2,500 total
Exercise: $11.56From: 2021-06-30Exp: 2026-06-30→ Common Stock (2,500 underlying)
Award
Stock Option (Right to Buy)
2020-06-30+2,500→ 2,500 total
Exercise: $1.50From: 2020-06-30Exp: 2025-06-30→ Common Stock (2,500 underlying)

Holdings

Warrants to Purchase Common Stock
Exercise: $0.28From: 2019-05-15Exp: 2023-05-15→ Common Stock (217,391 underlying)
217,391
Common Stock
217,391

Footnotes (5)

[F1]On October 14, 2020, the common stock of LFMD, Inc. had a reverse stock split 1-for-5, resulting in a decrease of the reporting person's ownership of 869,566 shares of common stock.
[F2]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.80 to $4.02, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth.
[F3]Issued in connection with Exchange Agreement dated September 22, 2020 whereby shares of common stock and warrants were exchanged for outstanding debt.
[F4]Issued as director's compensation.
[F5]Issued pursuant to anti-dilution provisions contained in the Securities Purchase Agreement dated May 31, 2019.

Documents

1 file

4
primary_doc.xmlPrimary
PRIMARY DOCUMENT